Back to STATE STREET CORP STATE STREET CORP

RARERARE
10 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ULTRAGENYX PHARMACEUTICAL IN

STATE STREET CORP holds 5M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $105.2M as of 2026-Q1. The position was increased (+16.7% shares). RARE represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$105.2M

Current Shares

5M

Total Value Change

-$50.3M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
5M
+16.7%
$105.2M0.0%$22.07
35
2025-Q4
Increased
4.3M
+16.5%
$99M0.0%$22.78
35
2025-Q3
Increased
3.7M
+43.5%
$111.1M0.0%$30.36
40
2025-Q2
Decreased
2.6M
-1.8%
$93.5M0.0%$36.52
0
2025-Q1
Decreased
2.6M
-3.8%
$94.8M0.0%$37.82
0
2024-Q4
Increased
2.7M
+2.2%
$114.5M0.0%$42.27
31
2024-Q3
Decreased
2.7M
-1.2%
$148M0.0%$54.43
0
2024-Q2
Decreased
2.7M
-5.4%
$110.9M0.0%$41.10
0
2024-Q1
Decreased
2.9M
-12.3%
$133.1M0.0%$46.69
0
2023-Q4
New
3.3M
-
$155.5M0.0%$47.82
42

Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used